tirzepatide and naion GLP-1 RAs and NAION: What Clinicians Should Know Weight-Loss Drugs and Your Eyes:
Description
No Botox needed.
Its a dual-action GLP-1/GIP that is approved by the FDA for people with obesity BMI 30, or overweight BMI 27 plus a weight-related condition, along with diet and exercise changes
It is a prescription hormonal medicine used to treat selected
however, these increases are not expected to be of clinical relevance
